Rethinking Cancer Screening: The diMARIE Study Begins

Health starts with knowledge about yourself. Some answers change how you look ahead. In the diMARIE study, participants receive a personalized cancer risk analysis, an individual screening plan, and a personal consultation. Conducted in collaboration with the University Hospital of Würzburg.

Digital. Personalized. Understandable.

How can cancer screening become more personalized, understandable, and effective?

This question lies at the heart of the diMARIE study – an innovative research project by Oncosia Scientific in collaboration with the University Hospital of Würzburg. Our goal is to establish a digital, evidence-based tool for personalized cancer screening and awareness.

Early detection of cancer leads to better chances of recovery and reduces the burden on both patients and the healthcare system. Studies show that individuals with higher health literacy are more likely to participate in preventive programs. At the same time, a confusing variety of screening options, unclear information, uncertainties in dealing with individual risks – and the lack of tools for systematic personalization in clinical practice – make access and orientation difficult for many.

This is where diMARIE comes in: Using our medical software OncoPrevia, we collect comprehensive personal and family risk factors, calculate validated cancer risks – and derive evidence-based, tailored screening recommendations. The digital analysis is complemented by structured consultations. This creates transparency, promotes health literacy, and supports physicians in making precise, personalized recommendations.

At the same time, the study evaluates the software's user-friendliness and acceptance – paving the way for future research projects with OncoPrevia that aim to demonstrate its broader value for regular healthcare implementation.

What is behind diMARIE?

In October 2024, our company name changed from Curie Science Center to Oncosia Scientific – a step that reflects our development as a software provider in personalized, risk-adapted cancer screening. The diMARIE study carries this transition in its name: Inspired by scientist Marie Skłodowska Curie, diMARIE now symbolically stands for "Digital Analysis of Individual Cancer Risk Factors and Evaluation of Software Usability."

Concretely, this means: Participants receive a personalized cancer risk analysis using OncoPrevia, our CE-certified and MDR-compliant medical software. Based on scientific S3 guidelines, we assess the individual risk for certain types of cancer – and derive concrete screening recommendations. This results in a screening plan that is both understandable and evidence-based.

As part of the diMARIE study, each participant receives a personal consultation. These sessions not only explain individual risk profiles but also provide concrete options for risk reduction. They offer space for questions, clarify recommended screening steps, and foster confidence in one's health journey. The result: a real dialogue – informed, empathetic, and eye-to-eye.

Who can participate?

The diMARIE study is open to all adults aged 18 and over – regardless of gender. Participants must have good German language skills and a willingness to actively engage with their own health. People with a current or past cancer diagnosis or mental health instability are excluded.

Participation is fully remote, free of charge, and involves no medical risks. The study is based solely on digital questionnaires and structured consultations – with no physical examinations required. It's a simple, safe way to learn more about your personal cancer risk and receive a tailored screening plan.

For Interested Medical Practices

Whether you are a general practitioner, specialist clinic, or psychotherapy provider – prevention should have a permanent place in every practice. Want to raise awareness among your patients about cancer screening while supporting research? Join the diMARIE study!

We are happy to send you free flyers to display in your practice. Just email us at mail@oncosia.de – we look forward to your support.

Join Now & Help Shape the Future of Cancer Screening

By participating, you help rethink prevention – personalized, digital, and accessible to all. Participation is free, secure, and risk-free.

Start Now: In just a few minutes, you'll receive your personal participant ID and can get started.

For more information about the study, process, and study physicians, visit: www.oncosia.de/for-patients/dimarie

Questions beforehand? We're happy to help – all contact details are listed at the bottom of the info page.

We look forward to your participation – and to shaping the future of cancer screening together.